Literature DB >> 14734370

Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes.

M K Sinha1, D Roy, D C Gaze, P O Collinson, J C Kaski.   

Abstract

BACKGROUND: Diagnosis of cardiac ischaemia in patients attending emergency departments (ED) with symptoms of acute coronary syndromes is often difficult. Cardiac troponin (cTn) is sensitive and specific for the detection of myocardial damage but may not rise during reversible myocardial ischaemia. Ischemia Modified Albumin (IMA) has recently been shown to be a sensitive and early biochemical marker of ischaemia. METHODS AND
RESULTS: This study evaluated IMA in conjunction with ECG and cTn in 208 patients presenting to the ED within three hours of acute chest pain. At presentation, a 12-lead ECG was recorded and blood taken for IMA and cardiac troponin T (cTnT). Patients underwent standardised triage, diagnostic procedures, and treatment. Results of IMA, ECG, and cTnT, alone and in combination, were correlated with final diagnoses of non-ischaemic chest pain, unstable angina, ST segment elevation, and non-ST segment elevation myocardial infarction. In the whole patient group, sensitivity of IMA at presentation for an ischaemic origin of chest pain was 82%, compared with 45% of ECG and 20% of cTnT. IMA used together with cTnT or ECG, had a sensitivity of 90% and 92%, respectively. All three tests combined identified 95% of patients whose chest pain was attributable to ischaemic heart disease. In patients with unstable angina, sensitivity of IMA used alone was equivalent to that of IMA and ECG combined.
CONCLUSIONS: IMA is highly sensitive for the diagnosis of myocardial ischaemia in patients presenting with symptoms of acute chest pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734370      PMCID: PMC1756335          DOI: 10.1136/emj.2003.006007

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  29 in total

Review 1.  Coronary artery spasm and vasoconstriction. The case for a distinction.

Authors:  A Maseri; G Davies; D Hackett; J C Kaski
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

2.  Usefulness of two-dimensional echocardiography for immediate detection of myocardial ischemia in the emergency room.

Authors:  C H Peels; C A Visser; A J Kupper; F C Visser; J P Roos
Journal:  Am J Cardiol       Date:  1990-03-15       Impact factor: 2.778

3.  Summary statistics for acute cardiac ischemia and chest pain visits to United States EDs, 1995-1996.

Authors:  C W Burt
Journal:  Am J Emerg Med       Date:  1999-10       Impact factor: 2.469

4.  Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog.

Authors:  A N Lieberman; J L Weiss; B I Jugdutt; L C Becker; B H Bulkley; J G Garrison; G M Hutchins; C A Kallman; M L Weisfeldt
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

5.  Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients.

Authors:  A S Iskandrian; J Heo; B Kong; E Lyons
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

6.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.

Authors:  E Falk
Journal:  Circulation       Date:  1985-04       Impact factor: 29.690

7.  A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain.

Authors:  L Goldman; M Weinberg; M Weisberg; R Olshen; E F Cook; R K Sargent; G A Lamas; C Dennis; C Wilson; L Deckelbaum; H Fineberg; R Stiratelli
Journal:  N Engl J Med       Date:  1982-09-02       Impact factor: 91.245

8.  Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.

Authors:  Nadhipuram V Bhagavan; Ernest M Lai; Patricia A Rios; Jinsheng Yang; Anna M Ortega-Lopez; Hiroko Shinoda; Stacey A A Honda; Carlos N Rios; Cheryl E Sugiyama; Chung-Eun Ha
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

9.  Reactivity of eccentric and concentric coronary stenoses in patients with chronic stable angina.

Authors:  J C Kaski; D Tousoulis; A W Haider; S Gavrielides; F Crea; A Maseri
Journal:  J Am Coll Cardiol       Date:  1991-03-01       Impact factor: 24.094

10.  Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings.

Authors:  L Bilodeau; P Théroux; J Grégoire; D Gagnon; A Arsenault
Journal:  J Am Coll Cardiol       Date:  1991-12       Impact factor: 24.094

View more
  57 in total

Review 1.  Markers to define ischemia: are they ready for prime time use in patients with acute coronary syndromes?

Authors:  Jesse Adams
Journal:  Curr Cardiol Rep       Date:  2004-07       Impact factor: 2.931

2.  Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin.

Authors:  D Roy; J Quiles; D C Gaze; P Collinson; J C Kaski; G F Baxter
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

3.  When prognosis precedes diagnosis: putting the cart before the horse.

Authors:  Marc S Sabatine
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

4.  Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction.

Authors:  M K Sinha; J M Vazquez; R Calvino; D C Gaze; P O Collinson; J C Kaski
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

5.  Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome.

Authors:  Andrew Worster; P J Devereaux; Diane Heels-Ansdell; Gordon H Guyatt; John Opie; Farouk Mookadam; Stephen A Hill
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

6.  Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values.

Authors:  Cui Liyan; Zhang Jie; Hu Xiaozhou
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

7.  Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes.

Authors:  Cui Liyan; Zhang Jie; Wu Yonghua; Hu Xiaozhou
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

8.  Effect of hemodialysis on traditional and innovative cardiac markers.

Authors:  Martina Montagnana; Giuseppe Lippi; Nicola Tessitore; Gian Luca Salvagno; Giovanni Targher; Matteo Gelati; Antonio Lupo; Gian Cesare Guidi
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

9.  Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease.

Authors:  Luiz Carlos Cichota; Rafael Noal Moresco; Marta Maria Medeiros Frescura Duarte; José Edson Paz da Silva
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

10.  Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome.

Authors:  Prema Gurumurthy; Sai Krishna Borra; Rama Krishna Reddy Yeruva; Dolice Victor; Sai Babu; K M Cherian
Journal:  Indian J Clin Biochem       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.